Compass Financial Management’s GSK GSK Stock Holding History

Compass Financial Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34K	Buy	+650	New	+$34.4K	﹤0.01%	765

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Compass Financial Management's GSK Position: Q2 2026 in Review

Compass Financial Management opened a new position in GSK (GSK) in Q2 2026: 650 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #765 among its holdings.

999 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Compass Financial Management held 650 shares of GSK worth $34K as of Q2 2026.
GSK was a new Compass Financial Management position in Q2 2026.
GSK made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #765 holding.
999 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.